Relief Therapeutics Holding SA (RLFTF)
1.44
+0.06
(+4.73%)
USD |
OTCM |
May 17, 14:26
Relief Therapeutics Total Liabilities (Quarterly): 28.77M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 28.77M |
| June 30, 2023 | 34.93M |
| June 30, 2023 | 34.93M |
| December 31, 2022 | 46.79M |
| June 30, 2022 | 63.29M |
| June 30, 2022 | 63.29M |
| December 31, 2021 | 76.67M |
| June 30, 2021 | 60.50M |
| June 30, 2021 | 60.50M |
| December 31, 2020 | 12.59M |
| June 30, 2020 | 10.60M |
| June 30, 2020 | 10.60M |
| December 31, 2019 | 5.744M |
| June 30, 2019 | 10.56M |
| June 30, 2019 | 10.56M |
| December 31, 2018 | 14.52M |
| June 30, 2018 | 14.36M |
| June 30, 2018 | 14.36M |
| December 31, 2017 | 10.29M |
| June 30, 2017 | 9.690M |
| June 30, 2017 | 9.690M |
| December 31, 2016 | 9.028M |
| Date | Value |
|---|---|
| June 30, 2016 | 6.493M |
| June 30, 2016 | 6.493M |
| December 31, 2015 | 0.0668M |
| June 30, 2015 | 12.87M |
| June 30, 2015 | 12.87M |
| December 31, 2014 | 15.44M |
| June 30, 2014 | 24.59M |
| June 30, 2014 | 24.59M |
| December 31, 2013 | 29.55M |
| June 30, 2013 | 4.074M |
| June 30, 2013 | 4.074M |
| December 31, 2012 | 29.94M |
| June 30, 2012 | 3.140M |
| June 30, 2012 | 3.140M |
| December 31, 2011 | 32.32M |
| June 30, 2011 | 7.090M |
| December 31, 2010 | 6.341M |
| June 30, 2010 | 6.419M |
| December 31, 2009 | 8.194M |
| June 30, 2009 | 10.88M |
| December 31, 2008 | 7.228M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.744M
Minimum
Dec 2019
76.67M
Maximum
Dec 2021
35.36M
Average
34.93M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 25.05M |
| CRISPR Therapeutics AG | 355.08M |
| Addex Therapeutics Ltd | 4.163M |
| NLS Pharmaceutics Ltd | 10.68M |
| Molecular Partners AG | 26.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 90.95M |
| Shareholders Equity (Quarterly) | 62.18M |
| Debt to Equity Ratio | 0.0066 |
| Current Ratio | 2.649 |
| Net Debt Paydown Yield | 0.01% |